Fig. 1
From: Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
Protein expression profiles of MCF7 LTLT cells versus normal MCF7, T47D, and MCF7aro cells. The cells were assayed by immunoblot with antibodies against (A) ERα; (B) HER2; (C) GR; (D) AR; (E) PR. β-actin was used as an internal loading control. For AR and HER2, samples were run on a WES (ProteinSimple). For ERα, GR, and PR, one of two representative experiments were shown